BRPI0923836A2 - Composições farmacêuticas orais contendo opióide e métodos - Google Patents
Composições farmacêuticas orais contendo opióide e métodosInfo
- Publication number
- BRPI0923836A2 BRPI0923836A2 BRPI0923836-0A BRPI0923836A BRPI0923836A2 BR PI0923836 A2 BRPI0923836 A2 BR PI0923836A2 BR PI0923836 A BRPI0923836 A BR PI0923836A BR PI0923836 A2 BRPI0923836 A2 BR PI0923836A2
- Authority
- BR
- Brazil
- Prior art keywords
- opioid
- methods
- pharmaceutical compositions
- oral pharmaceutical
- containing oral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14176508P | 2008-12-31 | 2008-12-31 | |
PCT/US2009/069902 WO2010078486A2 (en) | 2008-12-31 | 2009-12-31 | Opioid-containing oral pharmaceutical compositions and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0923836A2 true BRPI0923836A2 (pt) | 2015-07-21 |
Family
ID=42260778
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0923836-0A BRPI0923836A2 (pt) | 2008-12-31 | 2009-12-31 | Composições farmacêuticas orais contendo opióide e métodos |
Country Status (7)
Country | Link |
---|---|
US (3) | US8362029B2 (pt) |
EP (1) | EP2381937A2 (pt) |
AU (1) | AU2009332963B2 (pt) |
BR (1) | BRPI0923836A2 (pt) |
CA (1) | CA2750144C (pt) |
CL (1) | CL2011001621A1 (pt) |
WO (1) | WO2010078486A2 (pt) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030068375A1 (en) | 2001-08-06 | 2003-04-10 | Curtis Wright | Pharmaceutical formulation containing gelling agent |
WO2005123039A1 (en) | 2004-06-12 | 2005-12-29 | Collegium Pharmaceutical, Inc. | Abuse-deterrent drug formulations |
US20100172989A1 (en) * | 2006-01-21 | 2010-07-08 | Abbott Laboratories | Abuse resistant melt extruded formulation having reduced alcohol interaction |
WO2009114648A1 (en) | 2008-03-11 | 2009-09-17 | Depomed Inc. | Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic |
US8372432B2 (en) | 2008-03-11 | 2013-02-12 | Depomed, Inc. | Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic |
CA2773521C (en) | 2009-09-17 | 2017-01-24 | Upsher-Smith Laboratories, Inc. | A sustained-release product comprising a combination of a non-opioid amine and a non-steroidal anti-inflammatory drug |
US10668060B2 (en) | 2009-12-10 | 2020-06-02 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
US8597681B2 (en) | 2009-12-22 | 2013-12-03 | Mallinckrodt Llc | Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans |
US9198861B2 (en) | 2009-12-22 | 2015-12-01 | Mallinckrodt Llc | Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans |
NZ603173A (en) | 2010-05-10 | 2014-10-31 | Euro Celtique Sa | Manufacturing of active-free granules and tablets comprising the same |
NZ603170A (en) | 2010-05-10 | 2015-04-24 | Euro Celtique Sa | Combination of active loaded granules with additional actives |
PE20130657A1 (es) | 2010-05-10 | 2013-06-15 | Euro Celtique Sa | Composiciones farmaceuticas que comprenden hidromorfona y naloxona |
CN103370058A (zh) | 2010-12-22 | 2013-10-23 | 普渡制药公司 | 包覆的抗篡改控制释放剂型 |
EP2654733B1 (en) | 2010-12-23 | 2016-04-06 | Purdue Pharma LP | Tamper resistant solid oral dosage forms |
US8858963B1 (en) | 2011-05-17 | 2014-10-14 | Mallinckrodt Llc | Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia |
US8658631B1 (en) | 2011-05-17 | 2014-02-25 | Mallinckrodt Llc | Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia |
US8741885B1 (en) | 2011-05-17 | 2014-06-03 | Mallinckrodt Llc | Gastric retentive extended release pharmaceutical compositions |
US10702485B2 (en) | 2011-07-09 | 2020-07-07 | Syntrix Biosystems Inc. | Compositions and methods for overcoming resistance to tramadol |
JP6593993B2 (ja) * | 2011-11-07 | 2019-10-23 | ネクター セラピューティクス | オピオイドアゴニスト化合物と鎮痛性化合物との組成物、剤形、および同時投与 |
US10525054B2 (en) | 2011-11-07 | 2020-01-07 | Inheris Biopharma, Inc. | Compositions, dosage forms, and co-administration of an opioid agonist compound and an analgesic compound |
AU2014215478B2 (en) | 2013-02-05 | 2018-09-13 | Purdue Pharma L.P. | Tamper resistant pharmaceutical formulations |
US10751287B2 (en) | 2013-03-15 | 2020-08-25 | Purdue Pharma L.P. | Tamper resistant pharmaceutical formulations |
WO2015023675A2 (en) | 2013-08-12 | 2015-02-19 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
US9770514B2 (en) | 2013-09-03 | 2017-09-26 | ExxPharma Therapeutics LLC | Tamper-resistant pharmaceutical dosage forms |
US9814710B2 (en) | 2013-11-13 | 2017-11-14 | Euro-Celtique S.A. | Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome |
US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
WO2015095391A1 (en) | 2013-12-17 | 2015-06-25 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
DK3169315T3 (da) | 2014-07-17 | 2020-08-10 | Pharmaceutical Manufacturing Res Services In | Væskefyldt doseringsform til forhindring af misbrug med øjeblikkelig frigivelse |
JP2017531026A (ja) | 2014-10-20 | 2017-10-19 | ファーマシューティカル マニュファクチュアリング リサーチ サービシズ,インコーポレーテッド | 徐放性乱用抑止性液体充填剤形 |
WO2017222575A1 (en) | 2016-06-23 | 2017-12-28 | Collegium Pharmaceutical, Inc. | Process of making more stable abuse-deterrent oral formulations |
WO2019046611A1 (en) * | 2017-08-31 | 2019-03-07 | Purdue Pharma L.P. | PHARMACEUTICAL DOSAGE FORMS |
Family Cites Families (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL58285A (en) | 1978-10-04 | 1983-10-31 | Merck & Co Inc | Pharmaceutical compositions having skeletal muscle relaxant activity,comprising cyclobenzaprine together with diflunisal |
FR2585246A1 (fr) * | 1985-07-26 | 1987-01-30 | Cortial | Procede d'obtention de formes pharmaceutiques solides a liberation prolongee |
DE3737154A1 (de) | 1986-11-03 | 1988-07-28 | Sandoz Ag | Analgetische praeparate |
US6127352A (en) | 1988-02-01 | 2000-10-03 | Uribe; Jose R. | Pharmaceutical compositions with analgesics containing codeine |
US5202128A (en) | 1989-01-06 | 1993-04-13 | F. H. Faulding & Co. Limited | Sustained release pharmaceutical composition |
US5330766A (en) | 1989-01-06 | 1994-07-19 | F. H. Faulding & Co. Limited | Sustained release pharmaceutical composition |
IT1255007B (it) | 1991-07-01 | 1995-10-11 | Altergon Sa | Sale solubile dell'ibuprofen c0n n-(2-idrossietil) pirrolidina e composizioni farmaceutiche che li contengono. |
AU661723B2 (en) | 1991-10-30 | 1995-08-03 | Mcneilab, Inc. | Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug |
US5681585A (en) | 1991-12-24 | 1997-10-28 | Euro-Celtique, S.A. | Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
US5580578A (en) | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
US5958459A (en) | 1991-12-24 | 1999-09-28 | Purdue Pharma L.P. | Opioid formulations having extended controlled released |
US5478577A (en) | 1993-11-23 | 1995-12-26 | Euroceltique, S.A. | Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
US5968551A (en) | 1991-12-24 | 1999-10-19 | Purdue Pharma L.P. | Orally administrable opioid formulations having extended duration of effect |
US7070806B2 (en) | 1992-01-27 | 2006-07-04 | Purdue Pharma Lp | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
JP3278192B2 (ja) | 1992-04-03 | 2002-04-30 | ロート製薬株式会社 | 徐放性液剤 |
GB9319568D0 (en) | 1993-09-22 | 1993-11-10 | Euro Celtique Sa | Pharmaceutical compositions and usages |
GB9422154D0 (en) | 1994-11-03 | 1994-12-21 | Euro Celtique Sa | Pharmaceutical compositions and method of producing the same |
US5965161A (en) | 1994-11-04 | 1999-10-12 | Euro-Celtique, S.A. | Extruded multi-particulates |
US5914129A (en) | 1996-07-23 | 1999-06-22 | Mauskop; Alexander | Analgesic composition for treatment of migraine headaches |
BE1011045A3 (fr) | 1997-03-14 | 1999-04-06 | Ucb Sa | Compositions pharmaceutiques pour la liberation controlee de substances actives. |
PT1685839E (pt) | 1997-12-22 | 2013-07-08 | Euro Celtique Sa | Forma de dosagem farmacêutica por via oral compreendendo uma combinação de um agonista opióide e de um antagonista opióide |
US6245357B1 (en) * | 1998-03-06 | 2001-06-12 | Alza Corporation | Extended release dosage form |
WO2000004879A1 (en) | 1998-07-24 | 2000-02-03 | Andrix Pharmaceuticals, Inc. | Granule modulating hydrogel system |
NZ511442A (en) | 1998-11-02 | 2003-02-28 | Elan Corp Plc | Multiparticulate modified release composition for multiple dosing of ADD patients with methylphenidate HCl |
EP1204406A2 (en) | 1999-07-29 | 2002-05-15 | Roxane Laboratories, Inc. | Opioid sustained-released formulation |
DE10023699A1 (de) | 1999-08-31 | 2001-04-19 | Gruenenthal Gmbh | Retardierte Darreichungsform enthaltend Tramadolsaccharinat |
ES2226886T3 (es) | 1999-08-31 | 2005-04-01 | Grunenthal Gmbh | Forma de administracion de accion retardada que contiene sacarinato de tramadol. |
DE19940944B4 (de) | 1999-08-31 | 2006-10-12 | Grünenthal GmbH | Retardierte, orale, pharmazeutische Darreichungsformen |
KR20130010512A (ko) | 1999-10-29 | 2013-01-28 | 유로-셀티크 소시에떼 아노뉨 | 서방성 하이드로코돈 제형 |
AP1665A (en) | 2000-02-08 | 2006-09-22 | Euro Celtique Sa | Tamper-resistant oral opioid agonist formulations. |
US6955821B2 (en) | 2000-04-28 | 2005-10-18 | Adams Laboratories, Inc. | Sustained release formulations of guaifenesin and additional drug ingredients |
KR100968128B1 (ko) | 2000-10-30 | 2010-07-06 | 유로-셀티크 소시에떼 아노뉨 | 서방성 하이드로코돈 제형 |
CN1525851A (zh) | 2001-05-11 | 2004-09-01 | ������ҩ������˾ | 抗滥用阿片样物质控释剂型 |
AU2002314968B2 (en) | 2001-06-08 | 2006-12-07 | Endo Pharmaceuticals, Inc. | Controlled release dosage forms using acrylic polymer, and process for making the same |
US20030068375A1 (en) | 2001-08-06 | 2003-04-10 | Curtis Wright | Pharmaceutical formulation containing gelling agent |
US20030049317A1 (en) | 2001-08-30 | 2003-03-13 | Lindsay David R. | Method and composition for reducing the danger and preventing the abuse of controlled release pharmaceutical formulations |
US20030068276A1 (en) | 2001-09-17 | 2003-04-10 | Lyn Hughes | Dosage forms |
US20030092724A1 (en) | 2001-09-18 | 2003-05-15 | Huaihung Kao | Combination sustained release-immediate release oral dosage forms with an opioid analgesic and a non-opioid analgesic |
CA2477004C (en) | 2002-02-22 | 2011-05-10 | Thomas Piccariello | Novel sustained release pharmaceutical compounds to prevent abuse of controlled substances |
CN100411611C (zh) | 2002-04-05 | 2008-08-20 | 欧洲凯尔蒂克公司 | 用于持续,不变且独立释放活性化合物的基质 |
AU2003228654A1 (en) | 2002-04-29 | 2003-11-17 | The General Hospital Corporation | Compositions and methods for preventing abuse of orally administered medications |
CA2498798A1 (en) | 2002-09-20 | 2004-04-01 | Alpharma, Inc. | Sustained-release opioid formulations and methods of use |
AU2003291103A1 (en) | 2002-11-15 | 2004-06-15 | Branded Products For The Future | Pharmaceutical composition |
CA2510465A1 (en) | 2002-12-18 | 2004-07-08 | Pain Therapeutics | Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats |
JP2007504239A (ja) | 2003-09-03 | 2007-03-01 | マリンクロッド・インコーポレイテッド | 顆粒状持続放出製剤およびその製造 |
CN102697704A (zh) | 2003-09-26 | 2012-10-03 | 阿尔扎公司 | 阿片类与非阿片类镇痛药的控释制剂 |
US20080031901A1 (en) | 2004-09-24 | 2008-02-07 | Abbott Laboratories | Sustained release monoeximic formulations of opioid and nonopioid analgesics |
WO2005034859A2 (en) | 2003-10-03 | 2005-04-21 | Elite Laboratories Inc. | Extended release formulations of opioids and method of use thereof |
US8709476B2 (en) | 2003-11-04 | 2014-04-29 | Supernus Pharmaceuticals, Inc. | Compositions of quaternary ammonium compounds containing bioavailability enhancers |
AU2004289221B2 (en) | 2003-11-04 | 2009-12-17 | Supernus Pharmaceuticals, Inc | Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atoms |
CA2537029C (en) | 2003-11-26 | 2013-03-12 | Likan Liang | Micellar systems useful for delivery of lipophilic or hydrophobic compounds |
US7201920B2 (en) | 2003-11-26 | 2007-04-10 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse of opioid containing dosage forms |
EP1711159B1 (en) * | 2003-12-30 | 2013-03-20 | Durect Corporation | Solid implants containing a block copolymer for controlled release of a gnrh compound |
US8541026B2 (en) | 2004-09-24 | 2013-09-24 | Abbvie Inc. | Sustained release formulations of opioid and nonopioid analgesics |
JP5046946B2 (ja) | 2004-10-15 | 2012-10-10 | スパーナス ファーマシューティカルズ インコーポレイテッド | 低乱用性薬学的製剤 |
US20060177380A1 (en) | 2004-11-24 | 2006-08-10 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse of orally administered pharmaceutical products |
US20060110327A1 (en) | 2004-11-24 | 2006-05-25 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse of orally administered pharmaceutical products |
WO2006133733A1 (en) | 2005-06-13 | 2006-12-21 | Flamel Technologies | Oral dosage form comprising an antimisuse system |
WO2007013975A2 (en) | 2005-07-20 | 2007-02-01 | Pharmorx Inc. | Composition containing an opioid agonist and a partial opioid agonist, preferably buprenorphine , for controlling abuse of medications |
US20070042041A1 (en) | 2005-08-17 | 2007-02-22 | Board Of Trustees Of The University Of Arkansas | Drug-surfactant complexes for sustained release |
US20070281016A1 (en) | 2006-06-06 | 2007-12-06 | Endo Pharmaceuticals Inc., A Delaware Corporation | Sustained release oxycodone composition with acrylic polymer and surfactant |
WO2008008120A1 (en) | 2006-07-14 | 2008-01-17 | Fmc Corporation | Solid form |
AR073435A1 (es) | 2006-10-18 | 2010-11-10 | Senosiain S A De C V Lab | Composicion farmaceutica de liberacion modificada de un musculo relajante y un aine |
TR200708925A1 (tr) | 2007-12-26 | 2009-07-21 | Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ | Kontrollü salım sağlayan flurbiprofen ve kas gevşetici kombinasyonları |
US20090214648A1 (en) | 2008-02-15 | 2009-08-27 | Malathi Kandakatla | Pharmaceutical formulations comprising ibuprofen and diphenhydramine |
US20090264454A1 (en) * | 2008-04-16 | 2009-10-22 | Nickell Robert P | Combined hydrocodone and analgesic formulation and method |
US7794750B2 (en) | 2008-06-20 | 2010-09-14 | Mutual Pharmaceutical Company, Inc. | Controlled-release formulations, method of manufacture, and use thereof |
CA2773521C (en) * | 2009-09-17 | 2017-01-24 | Upsher-Smith Laboratories, Inc. | A sustained-release product comprising a combination of a non-opioid amine and a non-steroidal anti-inflammatory drug |
-
2009
- 2009-12-31 BR BRPI0923836-0A patent/BRPI0923836A2/pt not_active IP Right Cessation
- 2009-12-31 WO PCT/US2009/069902 patent/WO2010078486A2/en active Application Filing
- 2009-12-31 CA CA2750144A patent/CA2750144C/en not_active Expired - Fee Related
- 2009-12-31 US US13/142,784 patent/US8362029B2/en not_active Expired - Fee Related
- 2009-12-31 AU AU2009332963A patent/AU2009332963B2/en not_active Ceased
- 2009-12-31 EP EP09795891A patent/EP2381937A2/en not_active Withdrawn
-
2011
- 2011-06-30 CL CL2011001621A patent/CL2011001621A1/es unknown
-
2012
- 2012-12-14 US US13/715,432 patent/US8987291B2/en not_active Expired - Fee Related
-
2015
- 2015-03-11 US US14/644,263 patent/US20150182462A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CL2011001621A1 (es) | 2012-03-30 |
US20110275658A1 (en) | 2011-11-10 |
AU2009332963B2 (en) | 2015-02-05 |
US20150182462A1 (en) | 2015-07-02 |
US8362029B2 (en) | 2013-01-29 |
CA2750144A1 (en) | 2010-07-08 |
AU2009332963A1 (en) | 2011-07-07 |
US20130123293A1 (en) | 2013-05-16 |
EP2381937A2 (en) | 2011-11-02 |
WO2010078486A3 (en) | 2010-08-26 |
WO2010078486A2 (en) | 2010-07-08 |
US8987291B2 (en) | 2015-03-24 |
CA2750144C (en) | 2016-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0923836A2 (pt) | Composições farmacêuticas orais contendo opióide e métodos | |
LTC2140867I2 (lt) | Farmacinė kompozicija | |
DK3345625T3 (da) | Farmaceutisk sammensætning og indgivelser deraf | |
BRPI0908596A2 (pt) | formulação e composição farmacêutica de liberação prolongada | |
DK3492069T3 (da) | Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid | |
BRPI0721651A2 (pt) | Composição farmacêutica | |
BRPI0715712A2 (pt) | Composição farmacêutica | |
BRPI0924137A2 (pt) | composição farmacêutica sólida compreendendo amlodipina e losartan com melhor estabilidade | |
BRPI0719393A2 (pt) | Composição farmacêutica | |
IL206594A (en) | The history of azinone-tetrahydropyridoindole and its containing pharmaceutical preparations | |
EP2154966A4 (en) | BENZIMIDAZOLES AND PHARMACEUTICAL COMPOSITIONS THEREOF | |
DK2120884T3 (da) | Farmaceutisk sammensætning | |
BRPI0716445A2 (pt) | composiÇço farmacÊutica | |
BRPI0720234A2 (pt) | Composição farmacêutica | |
DK2285413T3 (da) | Farmaceutisk sammensætning | |
BR112012000831A2 (pt) | compostos, composições farmacêuticas e métodos relacionados | |
DK2285357T3 (da) | Farmaceutisk sammensætning omfattende brivaracetam | |
PL2251006T3 (pl) | Mikrocząstki i ich kompozycje farmaceutyczne | |
BRPI0921313A2 (pt) | composição farmaucêutica | |
BRPI0820198A2 (pt) | composições farmacêuticas | |
ATE499368T1 (de) | Chinolonverbindung und pharmazeutische zusammensetzung | |
BRPI0912171A2 (pt) | composição farmacêutica | |
BRPI0912074A2 (pt) | composto e composição farmacêutica | |
BRPI0912656A2 (pt) | formulação farmacêutica sólida | |
ATE540672T1 (de) | Pharmazeutische zusammensetzung und verfahren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |